RxDoctor Payments Data

Taylor Payne, PA

Physician Assistant · Knoxville, TNNPI 1093304552

Payments from drug & device makers

$9,581in general payments, 2019–2025

Across 607 payments — averaging $15.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Pfizer$482
  • Otsuka America Pharmaceutical, Inc.$435
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$391
  • plus $4K from 37 others

What the payments were for

  • Food & beverage$9,48699%
  • Education$951%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,581 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$21,174
Medicare patients
142
Services billed
670

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide41$59,074
OzempicSemaglutide50$53,932
EliquisApixaban35$40,806
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$34,580
JardianceEmpagliflozin36$30,101
FarxigaDapagliflozin Propanediol18$22,044
MyrbetriqMirabegron15$12,181
Janumet XrSitagliptin Phos/Metformin Hcl11$7,483
Albuterol Sulfate HfaAlbuterol Sulfate92$2,432
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$2,070
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$1,553
Comfort Ez Pen NeedlePen Needle, Diabetic13$1,540
Omeprazole65$1,324
Gabapentin81$1,251
Atorvastatin Calcium133$1,137

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$235$59,07441 claims
Novo NordiskOzempic$1,493$53,93250 claims
PfizerEliquis$482$40,80635 claims
GSKTrelegy Ellipta$172$34,58041 claims
Boehringer IngelheimJardiance$294$30,10136 claims
AstraZenecaFarxiga$1,191$22,04418 claims
Astellas Pharma US IncMyrbetriq$95$12,18115 claims
MerckJanumet Xr$226$7,48311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →